Sunshine Biopharma Inc Warrant
SBFMW
6 hedge funds and large institutions have $1.26M invested in Sunshine Biopharma Inc Warrant in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.25% more ownership
Funds ownership: 0% → 0.25% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$617K |
| 2 |
EAM
Empery Asset Management
New York
|
+$164K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$52.1K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$41.9K |
| 5 |
CS
Clear Street
New York
|
+$9.86K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $876K | +$617K | +884,600 | New |
|
|
EAM
2
Empery Asset Management
New York
| $233K | +$164K | +235,200 | New |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| $74K | +$52.1K | +74,632 | New |
|
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| $59K | +$41.9K | +60,000 | New |
|
|
CS
5
Clear Street
New York
| $14K | +$9.86K | +14,126 | New |
|
6
UBS Group
Zurich,
Switzerland
| $1K | +$427 | +612 | New |
|
SBFMW Hedge Fund Activity: Q1 2022 in Review
6 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q1 2022, worth a combined $1.26M.
Buyers outnumbered sellers: 6 funds opened new SBFMW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $617K.
- 6 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $1.26M of Sunshine Biopharma Inc Warrant stock for Q1 2022.
- 6 funds opened new Sunshine Biopharma Inc Warrant positions in Q1 2022 and 0 closed out, a net change of +6 holders.
- The largest Sunshine Biopharma Inc Warrant buyer in Q1 2022 was Armistice Capital, an estimated $617K added.
Based on aggregated 13F filings for Q1 2022.